| DB ID | MyCo_3820 |
| Title | Clinical significance of low-positive histoplasma urine antigen results |
| Year | 2014 |
| PMID | 25031433 |
| Fungal Diseases involved | Histoplasma capsulatum infection |
| Associated Medical Condition | None |
| Genus | Histoplasma |
| Species | capsulatum |
| Organism | Histoplasma capsulatum |
| Ethical Statement | This study was approved by the Mayo Clinic Institutional Review Board. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Urine |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | UAg |
| Biomarker Full Name | Histoplasma urine antigen (UAg) |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | USA |
| Cohort | Here identified all Mayo Clinic patients who tested positive by the MiraVista UAg EIA between June 2005 and December 2012 (n = 118) |
| Cohort No. | 118 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Analytic |
| Analysis Method | Histoplasma capsulatum Quantitative Antigen enzyme immunoassay (EIA) |
| ELISA kits | None |
| Assay Data | Histoplasma capsulatum Quantitative Antigen enzyme immunoassay (EIA), MiraVista Diagnostics (Indianapolis, IN) |
| Validation Techniques used | Histoplasma capsulatum Quantitative Antigen enzyme immunoassay (EIA) |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
